← FDA Drug Approvals (Drugs@FDA)

LEVAQUIN

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2004-10-21

Drug application

FDA Application #

NDA021721

Application type

New Drug Application

Brand name

LEVAQUIN

Generic name

Levofloxacin

Active ingredients

LEVOFLOXACIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

JANSSEN PHARMS

First approval

2004-10-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown